BRPI1010761A2 - "composições semi-sólidas e produtos farmacêuticos" - Google Patents

"composições semi-sólidas e produtos farmacêuticos"

Info

Publication number
BRPI1010761A2
BRPI1010761A2 BRPI1010761A BRPI1010761A BRPI1010761A2 BR PI1010761 A2 BRPI1010761 A2 BR PI1010761A2 BR PI1010761 A BRPI1010761 A BR PI1010761A BR PI1010761 A BRPI1010761 A BR PI1010761A BR PI1010761 A2 BRPI1010761 A2 BR PI1010761A2
Authority
BR
Brazil
Prior art keywords
pharmaceuticals
semi
solid compositions
compositions
solid
Prior art date
Application number
BRPI1010761A
Other languages
English (en)
Inventor
Gry Stensrud
Original Assignee
Photocure Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure Asa filed Critical Photocure Asa
Publication of BRPI1010761A2 publication Critical patent/BRPI1010761A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/00615-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI1010761A 2009-06-11 2010-06-11 "composições semi-sólidas e produtos farmacêuticos" BRPI1010761A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09251537 2009-06-11
PCT/EP2010/003532 WO2010142457A1 (en) 2009-06-11 2010-06-11 Semi-solid compositions and pharmaceutical products

Publications (1)

Publication Number Publication Date
BRPI1010761A2 true BRPI1010761A2 (pt) 2016-03-22

Family

ID=41213323

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1010761A BRPI1010761A2 (pt) 2009-06-11 2010-06-11 "composições semi-sólidas e produtos farmacêuticos"

Country Status (20)

Country Link
US (2) US20120136055A1 (pt)
EP (2) EP3042647B1 (pt)
JP (1) JP5840604B2 (pt)
KR (2) KR20170116198A (pt)
CN (1) CN102458388B (pt)
AU (1) AU2010257753B2 (pt)
BR (1) BRPI1010761A2 (pt)
CA (1) CA2763923C (pt)
CL (1) CL2011003094A1 (pt)
DK (1) DK2440199T3 (pt)
ES (2) ES2821831T3 (pt)
HU (1) HUE026911T2 (pt)
MX (1) MX2011013127A (pt)
NZ (1) NZ596943A (pt)
PL (1) PL2440199T3 (pt)
RU (1) RU2526803C2 (pt)
SG (1) SG176688A1 (pt)
SI (1) SI2440199T1 (pt)
WO (1) WO2010142457A1 (pt)
ZA (1) ZA201109126B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2542208A1 (en) * 2010-03-01 2013-01-09 Photocure ASA Cosmetic compositions
US20130178787A1 (en) 2010-07-09 2013-07-11 Photocure Asa Dry Compositions and Devices Containing Such Dry Compostions for Use in Photodynamic Therapy or Photodynamic Diagnosis
EP2794004B1 (en) 2011-12-19 2020-07-29 Photocure ASA Irradiation apparatus
CN102670577B (zh) * 2012-05-18 2018-04-13 上海复旦张江生物医药股份有限公司 一种光敏剂组合物、其使用方法及用途
US20140067024A1 (en) 2012-08-30 2014-03-06 Photocure Asa Dual panel photodynamic therapy lamp
GB201221123D0 (en) 2012-11-23 2013-01-09 Photocure As Device for photodynamic treatment
CA2903020C (en) * 2013-02-28 2019-06-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid formulations and its compostions
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
GB201306369D0 (en) 2013-04-09 2013-05-22 Photocure As Irradiation device
DK3137053T3 (da) * 2014-04-30 2020-09-07 Allergan Inc Formuleringer af biologiske lægemidler til intravesikal instillation
CZ307444B6 (cs) * 2015-04-22 2018-08-29 Jakub Rak Mukoadhezivní polymerní film pro fotosenzitivní terapii v ústní dutině s obsahem fotosenzitizérů
GB201522309D0 (en) 2015-12-17 2016-02-03 Photocure Asa Use
DK3389716T3 (da) 2015-12-17 2022-04-11 Photocure Asa Fremgangsmåde til fotodynamisk terapi (pdt) for blærekræft
GB201522398D0 (en) 2015-12-18 2016-02-03 Photocure As Device for photodynamic therapy
WO2017168416A1 (en) * 2016-03-28 2017-10-05 Vidac Pharma Ltd. Stable pharmaceutical compositions for topical administration and uses thereof
US11039616B2 (en) 2016-05-10 2021-06-22 North Carolina State University Photodynamic compositions, methods of making, and uses thereof
US11884784B2 (en) 2016-05-10 2024-01-30 North Carolina State University Photodynamic compositions, methods of making, and uses thereof
GB2546128A (en) * 2016-09-28 2017-07-12 Photocure Asa Pharamaceutical compositions comprising hexaminolevulinic acid and methods of using the same
WO2018203874A1 (en) * 2017-05-01 2018-11-08 Cummins Inc. Systems and methods for controlling energy generation in a hybrid powertrain
FI3641882T3 (fi) * 2017-06-21 2023-12-14 Photocure Asa Menetelmä nestemäisen farmaseuttisen koostumuksen valmistamiseksi ja laite käytettäväksi sellaisessa menetelmässä
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
GB201808571D0 (en) * 2018-05-24 2018-07-11 Douglas Pharmaceuticals Ltd Pharmaceutical compositions
WO2020051585A1 (en) 2018-09-07 2020-03-12 R.P. Scherer Technologies, Llc Solid or semisolid lipid based dosage form stabilization through curing and addition of low hlb surfactant(s)
IL285384B2 (en) 2019-02-13 2024-11-01 Alpheus Medical Inc Non-invasive sonodynamic therapy
WO2020243319A1 (en) 2019-05-29 2020-12-03 Sonalasense, Inc. Sonosensitization
CN110575612A (zh) * 2019-09-27 2019-12-17 赵志国 女用光动力凝胶封包敷料装置
WO2022032283A2 (en) 2020-08-07 2022-02-10 Alpheus Medical, Inc. Ultrasound arrays for enhanced sonodynamic therapy for treating cancer
WO2025190314A1 (en) * 2024-03-12 2025-09-18 Asieris Pharmaceuticals (Shanghai) Co., Ltd. Photodynamic therapy for a cervix disorder or condition

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
JPH08175986A (ja) * 1994-09-20 1996-07-09 Johnson & Johnson Medical Inc 経皮活性を示す5−アミノレブリン酸含有薬学組成物
WO1996028412A1 (en) 1995-03-10 1996-09-19 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US7530461B2 (en) * 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
CA2229662A1 (en) * 1995-08-14 1997-02-27 Yona Tadir Endometrial ablation using photodynamic therapy with green porphyrins
DE10003620A1 (de) * 2000-01-28 2001-08-02 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln
US20020132035A1 (en) * 2001-01-10 2002-09-19 Dov Tamarkin Synthetic fat composition
GB0018527D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Composition
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds
GB0118251D0 (en) 2001-07-26 2001-09-19 Photocure Asa Method
US7264629B2 (en) * 2001-11-09 2007-09-04 Qlt, Inc. Photodynamic therapy for the treatment of hair loss
EP1312353A1 (en) 2001-11-16 2003-05-21 Ecole Polytechnique Federale De Lausanne (Epfl) Method for hair removal
US20040009212A1 (en) * 2002-01-30 2004-01-15 Pharma Power Biotec Co. Ltd. Mucoadhesive thermoresponsive medicament-carrier composition
CA2457214A1 (en) * 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
GB0424833D0 (en) 2004-11-10 2004-12-15 Photocure Asa Method
DE102005019628A1 (de) * 2005-04-26 2006-11-09 Technische Universität Braunschweig Formulierung zur dermalen Anwendung
GB0700580D0 (en) * 2007-01-11 2007-02-21 Photocure Asa Use
GB0724279D0 (en) 2007-12-12 2008-01-23 Photocure Asa Use
GB0900461D0 (en) 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device

Also Published As

Publication number Publication date
US20150238457A1 (en) 2015-08-27
WO2010142457A1 (en) 2010-12-16
HUE026911T2 (en) 2016-07-28
CA2763923A1 (en) 2010-12-16
ES2821831T3 (es) 2021-04-27
KR20120046155A (ko) 2012-05-09
AU2010257753B2 (en) 2014-09-18
AU2010257753A1 (en) 2012-01-12
PL2440199T3 (pl) 2016-10-31
EP2440199B1 (en) 2016-04-13
NZ596943A (en) 2013-09-27
KR20170116198A (ko) 2017-10-18
RU2011150919A (ru) 2013-07-20
EP2440199A1 (en) 2012-04-18
US20120136055A1 (en) 2012-05-31
ZA201109126B (en) 2013-02-27
CA2763923C (en) 2016-09-13
KR101797780B1 (ko) 2017-11-14
SI2440199T1 (sl) 2016-05-31
JP2012529452A (ja) 2012-11-22
ES2573085T3 (es) 2016-06-06
JP5840604B2 (ja) 2016-01-06
EP3042647A1 (en) 2016-07-13
SG176688A1 (en) 2012-01-30
CN102458388B (zh) 2016-09-28
US9326964B2 (en) 2016-05-03
CN102458388A (zh) 2012-05-16
CL2011003094A1 (es) 2012-07-20
MX2011013127A (es) 2012-02-21
DK2440199T3 (en) 2016-05-17
EP3042647B1 (en) 2020-08-26
HK1164163A1 (zh) 2012-09-21
RU2526803C2 (ru) 2014-08-27

Similar Documents

Publication Publication Date Title
BRPI1010761A2 (pt) "composições semi-sólidas e produtos farmacêuticos"
LTPA2018014I1 (lt) Farmacinė kompozicija 514
EP2280916A4 (en) HYDROCHLORFLUOROLEFINZUSAMMENSETZUNGEN
EP2316414A4 (en) HAIR CARE COMPOSITION
ME02979B (me) Kompozicije hemoglobina
BRPI0913806A2 (pt) "composição"
BR112012012872A2 (pt) "pirrolindinas de espiroindolinona"
BRPI0914375A2 (pt) ''composições antiperspirantes''
DK3492069T3 (da) Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
EP2487146A4 (en) hONEYCOMB STRUCTURE
BRPI1010909A2 (pt) "inseticida arilpirrolinas"
BRPI1011587A2 (pt) compostos e composições terapèuticas
BRPI0916123A2 (pt) "composição de xampu concentrada"
BRPI1013015A2 (pt) "osteosíntese com nanoprata"
EP2581431A4 (en) AEROSOL COMPOSITION
EP2463316A4 (en) acrylate composition
FR2933868B1 (fr) Compositions cosmetiques
EP2537907A4 (en) Release agent composition
BRPI1008215A2 (pt) "composição azeotrópica"
BR112012025270A2 (pt) "composição de cuidados pessoais"
EP2500932A4 (en) ADHESIVE COMPOSITION
BRPI0914383A2 (pt) "composição de shampoo condicionador"
BR112012000831A2 (pt) compostos, composições farmacêuticas e métodos relacionados
BRPI0914503A2 (pt) "composição de shampoo concentrado"
BRPI0820198A2 (pt) composições farmacêuticas

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/06/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2873 DE 27/01/2026 QUANTO AO TITULO.